Global Psilocybin Assisted Therapy Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Psilocybin Assisted Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Psilocybin Assisted Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Psilocybin Assisted Therapy market. Psilocybin Assisted Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psilocybin Assisted Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psilocybin Assisted Therapy market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psilocybin Assisted Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psilocybin Assisted Therapy market. It may include historical data, market segmentation by Type (e.g., Natural, Synthetic), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psilocybin Assisted Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psilocybin Assisted Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psilocybin Assisted Therapy industry. This include advancements in Psilocybin Assisted Therapy technology, Psilocybin Assisted Therapy new entrants, Psilocybin Assisted Therapy new investment, and other innovations that are shaping the future of Psilocybin Assisted Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psilocybin Assisted Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Psilocybin Assisted Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psilocybin Assisted Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psilocybin Assisted Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psilocybin Assisted Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psilocybin Assisted Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psilocybin Assisted Therapy market.
Market Segmentation:
Psilocybin Assisted Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Psilocybin Assisted Therapy market?
What factors are driving Psilocybin Assisted Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Psilocybin Assisted Therapy market opportunities vary by end market size?
How does Psilocybin Assisted Therapy break out type, application?
According to our LPI (LP Information) latest study, the global Psilocybin Assisted Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Psilocybin Assisted Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Psilocybin Assisted Therapy market. Psilocybin Assisted Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psilocybin Assisted Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psilocybin Assisted Therapy market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psilocybin Assisted Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psilocybin Assisted Therapy market. It may include historical data, market segmentation by Type (e.g., Natural, Synthetic), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psilocybin Assisted Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psilocybin Assisted Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psilocybin Assisted Therapy industry. This include advancements in Psilocybin Assisted Therapy technology, Psilocybin Assisted Therapy new entrants, Psilocybin Assisted Therapy new investment, and other innovations that are shaping the future of Psilocybin Assisted Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psilocybin Assisted Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Psilocybin Assisted Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psilocybin Assisted Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psilocybin Assisted Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psilocybin Assisted Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psilocybin Assisted Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psilocybin Assisted Therapy market.
Market Segmentation:
Psilocybin Assisted Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Natural
- Synthetic
- Cluster Headaches
- Anxiety Disorders
- Psychiatric Disorders
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MindMed
- Compass Pathways
- ATAI Life Sciences
- Field Trip
- DemeRx
- Eleusis
- Hikma Pharmaceuticals PLC
- Pfizer
- Verrian
- Jazz Pharmaceuticals
What is the 10-year outlook for the global Psilocybin Assisted Therapy market?
What factors are driving Psilocybin Assisted Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Psilocybin Assisted Therapy market opportunities vary by end market size?
How does Psilocybin Assisted Therapy break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psilocybin Assisted Therapy Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Psilocybin Assisted Therapy by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Psilocybin Assisted Therapy by Country/Region, 2019, 2023 & 2030
2.2 Psilocybin Assisted Therapy Segment by Type
2.2.1 Natural
2.2.2 Synthetic
2.3 Psilocybin Assisted Therapy Sales by Type
2.3.1 Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
2.3.2 Global Psilocybin Assisted Therapy Revenue and Market Share by Type (2019-2024)
2.3.3 Global Psilocybin Assisted Therapy Sale Price by Type (2019-2024)
2.4 Psilocybin Assisted Therapy Segment by Application
2.4.1 Cluster Headaches
2.4.2 Anxiety Disorders
2.4.3 Psychiatric Disorders
2.5 Psilocybin Assisted Therapy Sales by Application
2.5.1 Global Psilocybin Assisted Therapy Sale Market Share by Application (2019-2024)
2.5.2 Global Psilocybin Assisted Therapy Revenue and Market Share by Application (2019-2024)
2.5.3 Global Psilocybin Assisted Therapy Sale Price by Application (2019-2024)
3 GLOBAL PSILOCYBIN ASSISTED THERAPY BY COMPANY
3.1 Global Psilocybin Assisted Therapy Breakdown Data by Company
3.1.1 Global Psilocybin Assisted Therapy Annual Sales by Company (2019-2024)
3.1.2 Global Psilocybin Assisted Therapy Sales Market Share by Company (2019-2024)
3.2 Global Psilocybin Assisted Therapy Annual Revenue by Company (2019-2024)
3.2.1 Global Psilocybin Assisted Therapy Revenue by Company (2019-2024)
3.2.2 Global Psilocybin Assisted Therapy Revenue Market Share by Company (2019-2024)
3.3 Global Psilocybin Assisted Therapy Sale Price by Company
3.4 Key Manufacturers Psilocybin Assisted Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psilocybin Assisted Therapy Product Location Distribution
3.4.2 Players Psilocybin Assisted Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PSILOCYBIN ASSISTED THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Psilocybin Assisted Therapy Market Size by Geographic Region (2019-2024)
4.1.1 Global Psilocybin Assisted Therapy Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Psilocybin Assisted Therapy Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Psilocybin Assisted Therapy Market Size by Country/Region (2019-2024)
4.2.1 Global Psilocybin Assisted Therapy Annual Sales by Country/Region (2019-2024)
4.2.2 Global Psilocybin Assisted Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Psilocybin Assisted Therapy Sales Growth
4.4 APAC Psilocybin Assisted Therapy Sales Growth
4.5 Europe Psilocybin Assisted Therapy Sales Growth
4.6 Middle East & Africa Psilocybin Assisted Therapy Sales Growth
5 AMERICAS
5.1 Americas Psilocybin Assisted Therapy Sales by Country
5.1.1 Americas Psilocybin Assisted Therapy Sales by Country (2019-2024)
5.1.2 Americas Psilocybin Assisted Therapy Revenue by Country (2019-2024)
5.2 Americas Psilocybin Assisted Therapy Sales by Type
5.3 Americas Psilocybin Assisted Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psilocybin Assisted Therapy Sales by Region
6.1.1 APAC Psilocybin Assisted Therapy Sales by Region (2019-2024)
6.1.2 APAC Psilocybin Assisted Therapy Revenue by Region (2019-2024)
6.2 APAC Psilocybin Assisted Therapy Sales by Type
6.3 APAC Psilocybin Assisted Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psilocybin Assisted Therapy by Country
7.1.1 Europe Psilocybin Assisted Therapy Sales by Country (2019-2024)
7.1.2 Europe Psilocybin Assisted Therapy Revenue by Country (2019-2024)
7.2 Europe Psilocybin Assisted Therapy Sales by Type
7.3 Europe Psilocybin Assisted Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psilocybin Assisted Therapy by Country
8.1.1 Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2019-2024)
8.1.2 Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2019-2024)
8.2 Middle East & Africa Psilocybin Assisted Therapy Sales by Type
8.3 Middle East & Africa Psilocybin Assisted Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psilocybin Assisted Therapy
10.3 Manufacturing Process Analysis of Psilocybin Assisted Therapy
10.4 Industry Chain Structure of Psilocybin Assisted Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psilocybin Assisted Therapy Distributors
11.3 Psilocybin Assisted Therapy Customer
12 WORLD FORECAST REVIEW FOR PSILOCYBIN ASSISTED THERAPY BY GEOGRAPHIC REGION
12.1 Global Psilocybin Assisted Therapy Market Size Forecast by Region
12.1.1 Global Psilocybin Assisted Therapy Forecast by Region (2025-2030)
12.1.2 Global Psilocybin Assisted Therapy Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Psilocybin Assisted Therapy Forecast by Type
12.7 Global Psilocybin Assisted Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 MindMed
13.1.1 MindMed Company Information
13.1.2 MindMed Psilocybin Assisted Therapy Product Portfolios and Specifications
13.1.3 MindMed Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 MindMed Main Business Overview
13.1.5 MindMed Latest Developments
13.2 Compass Pathways
13.2.1 Compass Pathways Company Information
13.2.2 Compass Pathways Psilocybin Assisted Therapy Product Portfolios and Specifications
13.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Compass Pathways Main Business Overview
13.2.5 Compass Pathways Latest Developments
13.3 ATAI Life Sciences
13.3.1 ATAI Life Sciences Company Information
13.3.2 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolios and Specifications
13.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ATAI Life Sciences Main Business Overview
13.3.5 ATAI Life Sciences Latest Developments
13.4 Field Trip
13.4.1 Field Trip Company Information
13.4.2 Field Trip Psilocybin Assisted Therapy Product Portfolios and Specifications
13.4.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Field Trip Main Business Overview
13.4.5 Field Trip Latest Developments
13.5 DemeRx
13.5.1 DemeRx Company Information
13.5.2 DemeRx Psilocybin Assisted Therapy Product Portfolios and Specifications
13.5.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 DemeRx Main Business Overview
13.5.5 DemeRx Latest Developments
13.6 Eleusis
13.6.1 Eleusis Company Information
13.6.2 Eleusis Psilocybin Assisted Therapy Product Portfolios and Specifications
13.6.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eleusis Main Business Overview
13.6.5 Eleusis Latest Developments
13.7 Hikma Pharmaceuticals PLC
13.7.1 Hikma Pharmaceuticals PLC Company Information
13.7.2 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hikma Pharmaceuticals PLC Main Business Overview
13.7.5 Hikma Pharmaceuticals PLC Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Psilocybin Assisted Therapy Product Portfolios and Specifications
13.8.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Verrian
13.9.1 Verrian Company Information
13.9.2 Verrian Psilocybin Assisted Therapy Product Portfolios and Specifications
13.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Verrian Main Business Overview
13.9.5 Verrian Latest Developments
13.10 Jazz Pharmaceuticals
13.10.1 Jazz Pharmaceuticals Company Information
13.10.2 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolios and Specifications
13.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Jazz Pharmaceuticals Main Business Overview
13.10.5 Jazz Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psilocybin Assisted Therapy Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Psilocybin Assisted Therapy by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Psilocybin Assisted Therapy by Country/Region, 2019, 2023 & 2030
2.2 Psilocybin Assisted Therapy Segment by Type
2.2.1 Natural
2.2.2 Synthetic
2.3 Psilocybin Assisted Therapy Sales by Type
2.3.1 Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
2.3.2 Global Psilocybin Assisted Therapy Revenue and Market Share by Type (2019-2024)
2.3.3 Global Psilocybin Assisted Therapy Sale Price by Type (2019-2024)
2.4 Psilocybin Assisted Therapy Segment by Application
2.4.1 Cluster Headaches
2.4.2 Anxiety Disorders
2.4.3 Psychiatric Disorders
2.5 Psilocybin Assisted Therapy Sales by Application
2.5.1 Global Psilocybin Assisted Therapy Sale Market Share by Application (2019-2024)
2.5.2 Global Psilocybin Assisted Therapy Revenue and Market Share by Application (2019-2024)
2.5.3 Global Psilocybin Assisted Therapy Sale Price by Application (2019-2024)
3 GLOBAL PSILOCYBIN ASSISTED THERAPY BY COMPANY
3.1 Global Psilocybin Assisted Therapy Breakdown Data by Company
3.1.1 Global Psilocybin Assisted Therapy Annual Sales by Company (2019-2024)
3.1.2 Global Psilocybin Assisted Therapy Sales Market Share by Company (2019-2024)
3.2 Global Psilocybin Assisted Therapy Annual Revenue by Company (2019-2024)
3.2.1 Global Psilocybin Assisted Therapy Revenue by Company (2019-2024)
3.2.2 Global Psilocybin Assisted Therapy Revenue Market Share by Company (2019-2024)
3.3 Global Psilocybin Assisted Therapy Sale Price by Company
3.4 Key Manufacturers Psilocybin Assisted Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psilocybin Assisted Therapy Product Location Distribution
3.4.2 Players Psilocybin Assisted Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PSILOCYBIN ASSISTED THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Psilocybin Assisted Therapy Market Size by Geographic Region (2019-2024)
4.1.1 Global Psilocybin Assisted Therapy Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Psilocybin Assisted Therapy Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Psilocybin Assisted Therapy Market Size by Country/Region (2019-2024)
4.2.1 Global Psilocybin Assisted Therapy Annual Sales by Country/Region (2019-2024)
4.2.2 Global Psilocybin Assisted Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Psilocybin Assisted Therapy Sales Growth
4.4 APAC Psilocybin Assisted Therapy Sales Growth
4.5 Europe Psilocybin Assisted Therapy Sales Growth
4.6 Middle East & Africa Psilocybin Assisted Therapy Sales Growth
5 AMERICAS
5.1 Americas Psilocybin Assisted Therapy Sales by Country
5.1.1 Americas Psilocybin Assisted Therapy Sales by Country (2019-2024)
5.1.2 Americas Psilocybin Assisted Therapy Revenue by Country (2019-2024)
5.2 Americas Psilocybin Assisted Therapy Sales by Type
5.3 Americas Psilocybin Assisted Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psilocybin Assisted Therapy Sales by Region
6.1.1 APAC Psilocybin Assisted Therapy Sales by Region (2019-2024)
6.1.2 APAC Psilocybin Assisted Therapy Revenue by Region (2019-2024)
6.2 APAC Psilocybin Assisted Therapy Sales by Type
6.3 APAC Psilocybin Assisted Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psilocybin Assisted Therapy by Country
7.1.1 Europe Psilocybin Assisted Therapy Sales by Country (2019-2024)
7.1.2 Europe Psilocybin Assisted Therapy Revenue by Country (2019-2024)
7.2 Europe Psilocybin Assisted Therapy Sales by Type
7.3 Europe Psilocybin Assisted Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psilocybin Assisted Therapy by Country
8.1.1 Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2019-2024)
8.1.2 Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2019-2024)
8.2 Middle East & Africa Psilocybin Assisted Therapy Sales by Type
8.3 Middle East & Africa Psilocybin Assisted Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psilocybin Assisted Therapy
10.3 Manufacturing Process Analysis of Psilocybin Assisted Therapy
10.4 Industry Chain Structure of Psilocybin Assisted Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psilocybin Assisted Therapy Distributors
11.3 Psilocybin Assisted Therapy Customer
12 WORLD FORECAST REVIEW FOR PSILOCYBIN ASSISTED THERAPY BY GEOGRAPHIC REGION
12.1 Global Psilocybin Assisted Therapy Market Size Forecast by Region
12.1.1 Global Psilocybin Assisted Therapy Forecast by Region (2025-2030)
12.1.2 Global Psilocybin Assisted Therapy Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Psilocybin Assisted Therapy Forecast by Type
12.7 Global Psilocybin Assisted Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 MindMed
13.1.1 MindMed Company Information
13.1.2 MindMed Psilocybin Assisted Therapy Product Portfolios and Specifications
13.1.3 MindMed Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 MindMed Main Business Overview
13.1.5 MindMed Latest Developments
13.2 Compass Pathways
13.2.1 Compass Pathways Company Information
13.2.2 Compass Pathways Psilocybin Assisted Therapy Product Portfolios and Specifications
13.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Compass Pathways Main Business Overview
13.2.5 Compass Pathways Latest Developments
13.3 ATAI Life Sciences
13.3.1 ATAI Life Sciences Company Information
13.3.2 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolios and Specifications
13.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ATAI Life Sciences Main Business Overview
13.3.5 ATAI Life Sciences Latest Developments
13.4 Field Trip
13.4.1 Field Trip Company Information
13.4.2 Field Trip Psilocybin Assisted Therapy Product Portfolios and Specifications
13.4.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Field Trip Main Business Overview
13.4.5 Field Trip Latest Developments
13.5 DemeRx
13.5.1 DemeRx Company Information
13.5.2 DemeRx Psilocybin Assisted Therapy Product Portfolios and Specifications
13.5.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 DemeRx Main Business Overview
13.5.5 DemeRx Latest Developments
13.6 Eleusis
13.6.1 Eleusis Company Information
13.6.2 Eleusis Psilocybin Assisted Therapy Product Portfolios and Specifications
13.6.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Eleusis Main Business Overview
13.6.5 Eleusis Latest Developments
13.7 Hikma Pharmaceuticals PLC
13.7.1 Hikma Pharmaceuticals PLC Company Information
13.7.2 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hikma Pharmaceuticals PLC Main Business Overview
13.7.5 Hikma Pharmaceuticals PLC Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Psilocybin Assisted Therapy Product Portfolios and Specifications
13.8.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Verrian
13.9.1 Verrian Company Information
13.9.2 Verrian Psilocybin Assisted Therapy Product Portfolios and Specifications
13.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Verrian Main Business Overview
13.9.5 Verrian Latest Developments
13.10 Jazz Pharmaceuticals
13.10.1 Jazz Pharmaceuticals Company Information
13.10.2 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolios and Specifications
13.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Jazz Pharmaceuticals Main Business Overview
13.10.5 Jazz Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psilocybin Assisted Therapy Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Psilocybin Assisted Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Natural
Table 4. Major Players of Synthetic
Table 5. Global Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 6. Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Table 7. Global Psilocybin Assisted Therapy Revenue by Type (2019-2024) & ($ million)
Table 8. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2024)
Table 9. Global Psilocybin Assisted Therapy Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 11. Global Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Table 12. Global Psilocybin Assisted Therapy Revenue by Application (2019-2024)
Table 13. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2024)
Table 14. Global Psilocybin Assisted Therapy Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Psilocybin Assisted Therapy Sales by Company (2019-2024) & (K Units)
Table 16. Global Psilocybin Assisted Therapy Sales Market Share by Company (2019-2024)
Table 17. Global Psilocybin Assisted Therapy Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Psilocybin Assisted Therapy Revenue Market Share by Company (2019-2024)
Table 19. Global Psilocybin Assisted Therapy Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Psilocybin Assisted Therapy Producing Area Distribution and Sales Area
Table 21. Players Psilocybin Assisted Therapy Products Offered
Table 22. Psilocybin Assisted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Psilocybin Assisted Therapy Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Psilocybin Assisted Therapy Sales Market Share Geographic Region (2019-2024)
Table 27. Global Psilocybin Assisted Therapy Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Psilocybin Assisted Therapy Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Psilocybin Assisted Therapy Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Psilocybin Assisted Therapy Sales Market Share by Country/Region (2019-2024)
Table 31. Global Psilocybin Assisted Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Psilocybin Assisted Therapy Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 34. Americas Psilocybin Assisted Therapy Sales Market Share by Country (2019-2024)
Table 35. Americas Psilocybin Assisted Therapy Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2024)
Table 37. Americas Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 38. Americas Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 39. APAC Psilocybin Assisted Therapy Sales by Region (2019-2024) & (K Units)
Table 40. APAC Psilocybin Assisted Therapy Sales Market Share by Region (2019-2024)
Table 41. APAC Psilocybin Assisted Therapy Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2024)
Table 43. APAC Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 44. APAC Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 45. Europe Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 46. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2019-2024)
Table 47. Europe Psilocybin Assisted Therapy Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2024)
Table 49. Europe Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 50. Europe Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Psilocybin Assisted Therapy
Table 58. Key Market Challenges & Risks of Psilocybin Assisted Therapy
Table 59. Key Industry Trends of Psilocybin Assisted Therapy
Table 60. Psilocybin Assisted Therapy Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Psilocybin Assisted Therapy Distributors List
Table 63. Psilocybin Assisted Therapy Customer List
Table 64. Global Psilocybin Assisted Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Psilocybin Assisted Therapy Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Psilocybin Assisted Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Psilocybin Assisted Therapy Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Psilocybin Assisted Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Psilocybin Assisted Therapy Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Psilocybin Assisted Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Psilocybin Assisted Therapy Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Psilocybin Assisted Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Psilocybin Assisted Therapy Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Psilocybin Assisted Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Psilocybin Assisted Therapy Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Psilocybin Assisted Therapy Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Psilocybin Assisted Therapy Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. MindMed Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 79. MindMed Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 80. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. MindMed Main Business
Table 82. MindMed Latest Developments
Table 83. Compass Pathways Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 84. Compass Pathways Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 85. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Compass Pathways Main Business
Table 87. Compass Pathways Latest Developments
Table 88. ATAI Life Sciences Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 90. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. ATAI Life Sciences Main Business
Table 92. ATAI Life Sciences Latest Developments
Table 93. Field Trip Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. Field Trip Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 95. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Field Trip Main Business
Table 97. Field Trip Latest Developments
Table 98. DemeRx Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. DemeRx Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 100. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. DemeRx Main Business
Table 102. DemeRx Latest Developments
Table 103. Eleusis Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Eleusis Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 105. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Eleusis Main Business
Table 107. Eleusis Latest Developments
Table 108. Hikma Pharmaceuticals PLC Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 110. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Hikma Pharmaceuticals PLC Main Business
Table 112. Hikma Pharmaceuticals PLC Latest Developments
Table 113. Pfizer Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 115. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Verrian Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 119. Verrian Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 120. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Verrian Main Business
Table 122. Verrian Latest Developments
Table 123. Jazz Pharmaceuticals Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 124. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 125. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Jazz Pharmaceuticals Main Business
Table 127. Jazz Pharmaceuticals Latest Developments
Table 1. Psilocybin Assisted Therapy Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Psilocybin Assisted Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Natural
Table 4. Major Players of Synthetic
Table 5. Global Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 6. Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Table 7. Global Psilocybin Assisted Therapy Revenue by Type (2019-2024) & ($ million)
Table 8. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2024)
Table 9. Global Psilocybin Assisted Therapy Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 11. Global Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Table 12. Global Psilocybin Assisted Therapy Revenue by Application (2019-2024)
Table 13. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2024)
Table 14. Global Psilocybin Assisted Therapy Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Psilocybin Assisted Therapy Sales by Company (2019-2024) & (K Units)
Table 16. Global Psilocybin Assisted Therapy Sales Market Share by Company (2019-2024)
Table 17. Global Psilocybin Assisted Therapy Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Psilocybin Assisted Therapy Revenue Market Share by Company (2019-2024)
Table 19. Global Psilocybin Assisted Therapy Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Psilocybin Assisted Therapy Producing Area Distribution and Sales Area
Table 21. Players Psilocybin Assisted Therapy Products Offered
Table 22. Psilocybin Assisted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Psilocybin Assisted Therapy Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Psilocybin Assisted Therapy Sales Market Share Geographic Region (2019-2024)
Table 27. Global Psilocybin Assisted Therapy Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Psilocybin Assisted Therapy Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Psilocybin Assisted Therapy Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Psilocybin Assisted Therapy Sales Market Share by Country/Region (2019-2024)
Table 31. Global Psilocybin Assisted Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Psilocybin Assisted Therapy Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 34. Americas Psilocybin Assisted Therapy Sales Market Share by Country (2019-2024)
Table 35. Americas Psilocybin Assisted Therapy Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2024)
Table 37. Americas Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 38. Americas Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 39. APAC Psilocybin Assisted Therapy Sales by Region (2019-2024) & (K Units)
Table 40. APAC Psilocybin Assisted Therapy Sales Market Share by Region (2019-2024)
Table 41. APAC Psilocybin Assisted Therapy Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2024)
Table 43. APAC Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 44. APAC Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 45. Europe Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 46. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2019-2024)
Table 47. Europe Psilocybin Assisted Therapy Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2024)
Table 49. Europe Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 50. Europe Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Psilocybin Assisted Therapy
Table 58. Key Market Challenges & Risks of Psilocybin Assisted Therapy
Table 59. Key Industry Trends of Psilocybin Assisted Therapy
Table 60. Psilocybin Assisted Therapy Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Psilocybin Assisted Therapy Distributors List
Table 63. Psilocybin Assisted Therapy Customer List
Table 64. Global Psilocybin Assisted Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Psilocybin Assisted Therapy Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Psilocybin Assisted Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Psilocybin Assisted Therapy Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Psilocybin Assisted Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Psilocybin Assisted Therapy Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Psilocybin Assisted Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Psilocybin Assisted Therapy Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Psilocybin Assisted Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Psilocybin Assisted Therapy Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Psilocybin Assisted Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Psilocybin Assisted Therapy Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Psilocybin Assisted Therapy Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Psilocybin Assisted Therapy Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. MindMed Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 79. MindMed Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 80. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. MindMed Main Business
Table 82. MindMed Latest Developments
Table 83. Compass Pathways Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 84. Compass Pathways Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 85. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Compass Pathways Main Business
Table 87. Compass Pathways Latest Developments
Table 88. ATAI Life Sciences Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 90. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. ATAI Life Sciences Main Business
Table 92. ATAI Life Sciences Latest Developments
Table 93. Field Trip Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. Field Trip Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 95. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Field Trip Main Business
Table 97. Field Trip Latest Developments
Table 98. DemeRx Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. DemeRx Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 100. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. DemeRx Main Business
Table 102. DemeRx Latest Developments
Table 103. Eleusis Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Eleusis Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 105. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Eleusis Main Business
Table 107. Eleusis Latest Developments
Table 108. Hikma Pharmaceuticals PLC Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 110. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Hikma Pharmaceuticals PLC Main Business
Table 112. Hikma Pharmaceuticals PLC Latest Developments
Table 113. Pfizer Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 115. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. Verrian Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 119. Verrian Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 120. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Verrian Main Business
Table 122. Verrian Latest Developments
Table 123. Jazz Pharmaceuticals Basic Information, Psilocybin Assisted Therapy Manufacturing Base, Sales Area and Its Competitors
Table 124. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolios and Specifications
Table 125. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Jazz Pharmaceuticals Main Business
Table 127. Jazz Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Psilocybin Assisted Therapy
Figure 2. Psilocybin Assisted Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psilocybin Assisted Therapy Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Psilocybin Assisted Therapy Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Psilocybin Assisted Therapy Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Natural
Figure 10. Product Picture of Synthetic
Figure 11. Global Psilocybin Assisted Therapy Sales Market Share by Type in 2023
Figure 12. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2024)
Figure 13. Psilocybin Assisted Therapy Consumed in Cluster Headaches
Figure 14. Global Psilocybin Assisted Therapy Market: Cluster Headaches (2019-2024) & (K Units)
Figure 15. Psilocybin Assisted Therapy Consumed in Anxiety Disorders
Figure 16. Global Psilocybin Assisted Therapy Market: Anxiety Disorders (2019-2024) & (K Units)
Figure 17. Psilocybin Assisted Therapy Consumed in Psychiatric Disorders
Figure 18. Global Psilocybin Assisted Therapy Market: Psychiatric Disorders (2019-2024) & (K Units)
Figure 19. Global Psilocybin Assisted Therapy Sales Market Share by Application (2023)
Figure 20. Global Psilocybin Assisted Therapy Revenue Market Share by Application in 2023
Figure 21. Psilocybin Assisted Therapy Sales Market by Company in 2023 (K Units)
Figure 22. Global Psilocybin Assisted Therapy Sales Market Share by Company in 2023
Figure 23. Psilocybin Assisted Therapy Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Psilocybin Assisted Therapy Revenue Market Share by Company in 2023
Figure 25. Global Psilocybin Assisted Therapy Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Psilocybin Assisted Therapy Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 28. Americas Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 29. APAC Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 30. APAC Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 31. Europe Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 32. Europe Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 35. Americas Psilocybin Assisted Therapy Sales Market Share by Country in 2023
Figure 36. Americas Psilocybin Assisted Therapy Revenue Market Share by Country in 2023
Figure 37. Americas Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 38. Americas Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 39. United States Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Psilocybin Assisted Therapy Sales Market Share by Region in 2023
Figure 44. APAC Psilocybin Assisted Therapy Revenue Market Share by Regions in 2023
Figure 45. APAC Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 46. APAC Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 47. China Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Psilocybin Assisted Therapy Sales Market Share by Country in 2023
Figure 55. Europe Psilocybin Assisted Therapy Revenue Market Share by Country in 2023
Figure 56. Europe Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 57. Europe Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 58. Germany Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 67. Egypt Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Psilocybin Assisted Therapy in 2023
Figure 73. Manufacturing Process Analysis of Psilocybin Assisted Therapy
Figure 74. Industry Chain Structure of Psilocybin Assisted Therapy
Figure 75. Channels of Distribution
Figure 76. Global Psilocybin Assisted Therapy Sales Market Forecast by Region (2025-2030)
Figure 77. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Psilocybin Assisted Therapy
Figure 2. Psilocybin Assisted Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psilocybin Assisted Therapy Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Psilocybin Assisted Therapy Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Psilocybin Assisted Therapy Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Natural
Figure 10. Product Picture of Synthetic
Figure 11. Global Psilocybin Assisted Therapy Sales Market Share by Type in 2023
Figure 12. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2024)
Figure 13. Psilocybin Assisted Therapy Consumed in Cluster Headaches
Figure 14. Global Psilocybin Assisted Therapy Market: Cluster Headaches (2019-2024) & (K Units)
Figure 15. Psilocybin Assisted Therapy Consumed in Anxiety Disorders
Figure 16. Global Psilocybin Assisted Therapy Market: Anxiety Disorders (2019-2024) & (K Units)
Figure 17. Psilocybin Assisted Therapy Consumed in Psychiatric Disorders
Figure 18. Global Psilocybin Assisted Therapy Market: Psychiatric Disorders (2019-2024) & (K Units)
Figure 19. Global Psilocybin Assisted Therapy Sales Market Share by Application (2023)
Figure 20. Global Psilocybin Assisted Therapy Revenue Market Share by Application in 2023
Figure 21. Psilocybin Assisted Therapy Sales Market by Company in 2023 (K Units)
Figure 22. Global Psilocybin Assisted Therapy Sales Market Share by Company in 2023
Figure 23. Psilocybin Assisted Therapy Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Psilocybin Assisted Therapy Revenue Market Share by Company in 2023
Figure 25. Global Psilocybin Assisted Therapy Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Psilocybin Assisted Therapy Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 28. Americas Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 29. APAC Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 30. APAC Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 31. Europe Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 32. Europe Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Psilocybin Assisted Therapy Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Psilocybin Assisted Therapy Revenue 2019-2024 ($ Millions)
Figure 35. Americas Psilocybin Assisted Therapy Sales Market Share by Country in 2023
Figure 36. Americas Psilocybin Assisted Therapy Revenue Market Share by Country in 2023
Figure 37. Americas Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 38. Americas Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 39. United States Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Psilocybin Assisted Therapy Sales Market Share by Region in 2023
Figure 44. APAC Psilocybin Assisted Therapy Revenue Market Share by Regions in 2023
Figure 45. APAC Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 46. APAC Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 47. China Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Psilocybin Assisted Therapy Sales Market Share by Country in 2023
Figure 55. Europe Psilocybin Assisted Therapy Revenue Market Share by Country in 2023
Figure 56. Europe Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 57. Europe Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 58. Germany Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Figure 67. Egypt Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Psilocybin Assisted Therapy Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Psilocybin Assisted Therapy in 2023
Figure 73. Manufacturing Process Analysis of Psilocybin Assisted Therapy
Figure 74. Industry Chain Structure of Psilocybin Assisted Therapy
Figure 75. Channels of Distribution
Figure 76. Global Psilocybin Assisted Therapy Sales Market Forecast by Region (2025-2030)
Figure 77. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Psilocybin Assisted Therapy Revenue Market Share Forecast by Application (2025-2030)
